PhoenixBio Co.,Ltd. (6190)

Market cap
¥1.5B
P/E ratio
19.6x
Phoenix Bio provides pharmaceutical testing services using PXB mice with human liver cells to help drug companies predict how medicines work in people.
Period EndGross margin (%) YoY (%)
Mar 31, 202676.7+5.80%
Mar 31, 202572.5+4.08%
Mar 31, 202469.7-4.92%
Mar 31, 202373.3+33.39%
Mar 31, 202254.9-5.33%
Mar 31, 202158-12.17%
Mar 31, 202066.1-4.67%
Mar 31, 201969.3+23.66%
Mar 31, 201856-18.01%
Mar 31, 201768.4+0.40%
Mar 31, 201668.1-2.21%
Mar 31, 201569.6
AI Chat